As of 2026-08-11, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 44.86 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.20 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is 968.1%.
The range of the Relative Valuation is 23.19 - 86.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 32.2x | 22.2x |
| Forward P/E multiples | 14.0x - 21.1x | 18.4x |
| Fair Price | 23.19 - 86.42 | 44.86 |
| Upside | 452.0% - 1957.6% | 968.1% |
| Date | P/E |
| 2026-08-07 | 1.60 |
| 2026-08-06 | 1.60 |
| 2026-08-05 | 1.61 |
| 2026-08-04 | 1.66 |
| 2026-08-03 | 1.64 |
| 2026-07-31 | 1.52 |
| 2026-07-30 | 1.54 |
| 2026-07-29 | 1.48 |
| 2026-07-28 | 1.56 |
| 2026-07-27 | 1.55 |
| 2026-07-24 | 1.50 |
| 2026-07-23 | 1.55 |
| 2026-07-22 | 1.50 |
| 2026-07-21 | 1.50 |
| 2026-07-20 | 1.53 |
| 2026-07-17 | 1.50 |
| 2026-07-16 | 1.51 |
| 2026-07-15 | 1.51 |
| 2026-07-14 | 1.49 |
| 2026-07-13 | 1.48 |
| 2026-07-10 | 1.51 |
| 2026-07-09 | 1.56 |
| 2026-07-08 | 1.60 |
| 2026-07-07 | 1.60 |
| 2026-07-06 | 1.70 |
| 2026-07-02 | 1.72 |
| 2026-07-01 | 1.72 |
| 2026-06-30 | 1.79 |
| 2026-06-29 | 1.73 |
| 2026-06-26 | 1.74 |
| 2026-06-25 | 1.87 |
| 2026-06-24 | 1.60 |
| 2026-06-23 | 1.56 |
| 2026-06-22 | 1.50 |
| 2026-06-18 | 1.45 |
| 2026-06-17 | 1.41 |
| 2026-06-16 | 1.41 |
| 2026-06-15 | 1.43 |
| 2026-06-12 | 1.44 |
| 2026-06-11 | 1.42 |
| 2026-06-10 | 1.38 |
| 2026-06-09 | 1.36 |
| 2026-06-08 | 1.36 |
| 2026-06-05 | 1.38 |
| 2026-06-04 | 1.42 |
| 2026-06-03 | 1.36 |
| 2026-06-02 | 1.34 |
| 2026-06-01 | 1.45 |
| 2026-05-29 | 1.48 |
| 2026-05-28 | 1.48 |